Guangdong Qingyunshan Pharmaceutical Co.
About
Company description
Guangdong Qingyunshan Pharmaceutical is a GMP certificate enterprise, founded in 1989, located in Guangdong, China. We have production lines for plant extraction, granules, capsules and tablets with NSF/ISO9001/ISO22000/HACCP/KOSHER/HALAL certification. Qingyunshan is a government certified High-tech Enterprise integrating R&D, production and sales of plant extract, functional foods health food and medicine. We have nearly 200 employees, including 50 R&D personnel, and 30 quality management personnel. For a long time, Qingyunshan Pharmaceutical has given full play to the advantages of experience in the field of plant extraction and separation based on the concept of "technological innovation is the core driving force of enterprise development". Qingyunshan is committed to providing high-quality products and excellent customer service.
Quick facts
Sales markets | Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
---|---|
Primary business activity | Manufacturer: Ingredients / Additives |
Affiliated categories: | Algae |Amino Acids |Anti-allergens More |
Upcoming events
Vitafoods Europe 2025
20 - 22 May 2025 Barcelona, Spain Visit us at stand 3F171 Book a meeting See our Exhibitor Profile See full Exhibitor ListRecently at
Vitafoods Europe 2024
14 - 16 May 2024 - Geneva, Switzerland We were at stand Q56 See our Exhibitor Profile See full Exhibitor ListNews about Guangdong Qingyunshan Pharmaceutical Co.
21 May 2024
Chinese "King of Herbs" - Ginseng
Ginseng is a kind of Chinese herbal medicine with high medicinal value and has a long history in the application of clinical medicine in China.
Read more21 May 2024
The “medicine chest” of Europe - Elderberry
Elderberry (Sambucus nigra L.) is a plant belonging to the Sambucus in the Adoxaceae. It occupies an important place in the history of European herbal medicine.
Read more21 May 2024
Apple cider vinegar and weight loss
Apple Cider Vinegar And Weight Loss (herealth.com)
Read more28 Apr 2023